Brief: Adamis Pharmaceuticals Issues Nationwide Voluntary Recall Of SYMJEPI Injection

DMK Pharmaceuticals

21/03/2022 20:07

March 21 (Reuters) - Adamis Pharmaceuticals Corp  ADMP.O :
    * ADAMIS PHARMACEUTICALS CORPORATION ISSUES NATIONWIDE
VOLUNTARY
RECALL OF SYMJEPI® (EPINEPHRINE) INJECTION FOR POTENTIAL
MANUFACTURING DEFECT
    * ADAMIS PHARMACEUTICALS CORP - VOLUNTARILY RECALLING
CERTAIN LOTS
OF SYMJEPI INJECTION PRE-FILLED SINGLE-DOSE SYRINGES TO CONSUMER
LEVEL
    * ADAMIS PHARMACEUTICALS CORP - BATCHES BEING RECALLED DUE
TO
POTENTIAL CLOGGING OF NEEDLE PREVENTING DISPENSING OF
EPINEPHRINE

Source text for Eikon:  ID:nGNX5vqwxP 
Further company coverage:  ADMP.O 

 ((Reuters.Briefs@thomsonreuters.com;))